ClinicalTrials.Veeva

Menu
C

CeCim | Santiago, Chile

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Tulisokibart
MK-7240
MK-0616
MK-7240-001
Bemarituzumab
Efinopegdutide
Efavaleukin Alfa
MK-6024-013
MK-7240-015
MK-7240-014

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 11 total trials

A Clinical Study of Tulisokibart (MK-7240) to Treat Rheumatoid Arthritis (RA) (MK-7240-014)

Researchers are looking for new ways to treat rheumatoid arthritis (RA). Methotrexate (MTX) is a standard (usual) treatment for RA. However, MTX and...

Active, not recruiting
Arthritis, Rheumatoid
Drug: Tulisokibart
Drug: Placebo

The purpose of this protocol is to evaluate the efficacy of tulisokibart in participants with moderately to severely active ulcerative colitis. Study...

Active, not recruiting
Ulcerative Colitis
Drug: IV Placebo
Drug: SC Placebo

The purpose of this protocol is to evaluate the efficacy and safety of tulisokibart in participants with moderately to severely active Crohn's diseas...

Enrolling
Crohn's Disease
Other: SC Placebo
Drug: IV Tulisokibart

This is a phase 3, randomized, placebo-controlled study of the efficacy and safety of enlicitide decanoate, an oral proprotein convertase subtilisin/...

Active, not recruiting
Arteriosclerosis
Hypercholesterolaemia
Drug: Enlicitide Decanoate
Drug: Placebo

Researchers are looking for new ways to treat Psoriatic Arthritis (PsA). This study will help find out if a study medicine called tulisokibart (MK-72...

Enrolling
Psoriatic Arthritis
Drug: Tulisokibart
Drug: Placebo

Trial sponsors

Merck Sharp & Dohme (MSD) logo
Amgen logo
Pfizer logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems